Factors associated with dengue hemorrhagic fever prevention practices: A cross-sectional study
https://doi.org/10.52235/lp.v7i2.863
Keywords:
attitude, dengue hemorrhagic fever, environmental factors, knowledge, prevention practicesAbstract
Background: Dengue Hemorrhagic Fever (DHF) remains an important public health problem in tropical regions, including Indonesia. Community prevention practices are essential because dengue transmission is closely related to household behavior, mosquito breeding sites, and routine vector control activities. This study examined knowledge, attitude, and selected environmental factors as determinants of DHF prevention practices in Laya Village.
Methods: This study used a quantitative analytic design with a cross-sectional approach. The population consisted of 359 households in Laya Village. A total of 78 respondents were selected using the Slovin formula and proportional allocation across five neighborhood clusters. Data were collected using structured questionnaires measuring knowledge, attitude, environmental factors, and DHF prevention practices. Environmental factors included the presence of discarded items, the habit of hanging clothes, and the use of mosquito repellents. Data were analyzed using univariate analysis and the Chi-square test.
Results: Most respondents had good knowledge (61.5%), good attitudes (52.6%), good management of discarded items (76.9%), good practice regarding hanging clothes (56.4%), and good use of mosquito repellents (83.3%). However, DHF prevention practices were mostly categorized as poor (51.3%), followed by adequate (42.3%) and good (6.4%). Bivariate analysis showed a significant relationship between knowledge and DHF prevention practices (p = 0.008). Attitude (p = 0.065), presence of discarded items (p = 0.119), habit of hanging clothes (p = 0.546), and use of mosquito repellents (p = 0.304) were not significantly associated with DHF prevention practices.
Conclusion: Knowledge was significantly associated with DHF prevention practices, while attitude and the three environmental indicators were not significantly associated. Continuous health education, community empowerment, and routine mosquito breeding site control are needed to strengthen DHF prevention at the household and community levels.
Downloads
References
Agustina, W., & Angela, V. (2024). Management of hyperthermia with the application of tepid water sponge in pediatric patients with hyperthermia: A case study. Indonesian Journal of Health Services, 1(3), 95-105. https://doi.org/10.63202/ijhs.v1i3.14
Aung, M. T. T., Tangpukdee, N., Limkittikul, K., Keeratiwasin, R., Sukharom, R., Hattasingh, W., & Sirinam, S. (2024). Early-phase factors associated with pediatric severe dengue in the Thai-Myanmar cross-border region. BMC Public Health, 24(1), 1957.
Aynekulu Mersha, D. G., Duijff, F., Langerak, T., Hakim, M. S., Martina, B., Goeijenbier, M., Dalm, V. A. S. H., van Lelyveld, S. F. L., & van Gorp, E. C. M. (2025). Effectiveness of antiviral, immunomodulatory and platelet-enhancing agents for treatment of dengue infection: A systematic review. Virulence, 16(1), 2587491.
Bernal, C., Ping, S., Rojas, A., Caballero, O., Stittleburg, V., de Guillén, Y., Langjahr, P., Pinsky, B. A., Von-Horoch, M., Luraschi, P., Cabral, S., Sánchez, M. C., Torres, A., Cardozo, F., & Waggoner, J. J. (2023). Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue. PLOS Neglected Tropical Diseases, 17(2), e0010750.
Castro, L. M., Fernandes, E. R., Quaresma, J. A. S., Lancelotti, C. L. P., Duarte, M. I. S., Carvalho, L. V., Penny, R., Vasconcelos, P. F. D. C., Mello, E. S., Sotto, M. N., & Pagliari, C. (2025). Histopathological alterations and dysregulation of type I interferon signaling in the human cerebral cortex during severe dengue. Journal of Medical Virology, 97(10), e70644.
Che Isa, Z., Lim, J. A., Ain, A. M., Othman, F. A., Kueh, Y. C., Tew, M. M., Masnan, M. J., & Ibrahim, A. (2023). Clinical profiles and predictors of survival in severe dengue cases. Singapore Medical Journal.
Chia, P. Y., Teo, A., & Yeo, T. W. (2022). Association of neutrophil mediators with dengue disease severity and cardiac impairment in adults. Journal of Infectious Diseases, 226(11), 1974–1984.
Cunha MS, de Moura Coletti T, Guerra JM, Ponce CC, Fernandes NCCA, Résio RA, Claro IM, Salles F, Lima Neto DF, Sabino E. A fatal case of dengue hemorrhagic fever associated with dengue virus 4 (DENV-4) in Brazil: genomic and histopathological findings. Braz J Microbiol. 2022 Sep;53(3):1305-1312.
Dinkes OKU. (2023). Profil Kesehatan Kabupaten Ogan Komering Ulu. Ogan Komering Ulu.
Dinkes Sumsel. (2023). Profil Kesehatan Provinsi Sumatera Selatan. Palembang.
Dong, B., Feng, S., & Feng, X. (2025). Advances in the epidemiology, pathogenesis, diagnostic methods, and vaccine development of dengue fever: A comprehensive review. Viral Immunology, 38(2), 53–60.
Durbin, A. P., Van Wesenbeeck, L., Pierce, K. K., Herrera-Taracena, G., Ebone, L., Buelens, A., Lutton, P., Sabundayo, B. P., Van Eygen, V., De Clerck, K., Fetter, I., Voge, N. V., Fang, X., Goeyvaerts, N., Vandendijck, Y., Mayfield, J., Lenz, O., De Meyer, S., Kakuda, T. N., He, H., Amaro-Carambot, E., Akli, R. D., Carmolli, M., De Marez, T., Whitehead, S. S., Van Loock, M., & Rasschaert, F. (2025). Daily mosnodenvir as dengue prophylaxis in a controlled human infection model. New England Journal of Medicine, 393(21), 2107–2118.
Enny, N. (2025). Demam Berdarah Dengue (1st ed.). Wawasan Ilmu.
Farina, J. M., Liblik, K., Iomini, P., Miranda-Arboleda, A. F., Saldarriaga, C., Mendoza, I., Zaidel, E. J., Rubio-Campal, J. M., Sosa-Liprandi, A., & Baranchuk, A. (2023). Infections and cardiovascular disease: JACC focus seminar 1/4. Journal of the American College of Cardiology, 81(1), 71–80.
Farsiu, N., Zandi, K., Rukerd, M. R. Z., Charostad, J., Bashash, D., Ghafari, S., Pardeshenas, M., Shahri, M., Mirkamali, H., Hassandarvish, P., Nakhaie, M., & AbuBakar, S. (2025). Challenges in the prevention and treatment of dengue fever: An emerging issue. American Journal of Tropical Medicine and Hygiene, 113(6), 1185–1199.
Goethals, O., Kaptein, S. J. F., Kesteleyn, B., Bonfanti, J. F., Van Wesenbeeck, L., Bardiot, D., Verschoor, E. J., Verstrepen, B. E., Fagrouch, Z., Putnak, J. R., Kiemel, D., Ackaert, O., Straetemans, R., Lachau-Durand, S., Geluykens, P., Crabbe, M., Thys, K., Stoops, B., Lenz, O., Tambuyzer, L., De Meyer, S., Dallmeier, K., McCracken, M. K., Gromowski, G. D., Rutvisuttinunt, W., Jarman, R. G., Karasavvas, N., Touret, F., Querat, G., de Lamballerie, X., Chatel-Chaix, L., Milligan, G. N., Beasley, D. W. C., Bourne, N., Barrett, A. D. T., Marchand, A., Jonckers, T. H. M., Raboisson, P., Simmen, K., Bartenschlager, R., Bogers, W. M., Neyts, J., & Van Loock, M. (2023). Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates. Nature, 615(7953), 678–686.
Gunale, B., Farinola, N., Kamat, C. D., Poonawalla, C. S., Pisal, S. S., Dhere, R. M., Miller, C., & Kulkarni, P. S. (2024). An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia. The Lancet Infectious Diseases, 24(6), 639–649.
Heryanto, E., & Meliyanti, F. (2022). Hubungan Pengetahuan, Pekerjaan, Dan Penyuluhan Dengan Tindakan Kepala Keluarga Dalam Upaya Pencegahan Penyakit Demam Berdarah Dengue (DBD). Lentera Perawat, 2(1), 8–16. https://doi.org/10.52235/lp.v2i1.156
Huang, Y.-J., Cheng, T.-L., Wang, Y.-T., Chen, C.-S., Leu, Y.-L., Chang, C.-S., Ho, C.-H., Chao, S.-W., Li, C.-T., & Chuang, C.-H. (2024). Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection. Journal of Virology, 98(4), e0125823.
Intan Manirah Niksan, Akhmad Dwi Priyatno, Lilis Suryani, & Yusnilasari. (2025). Environmental Sanitation Analysis of Dengue Fever Disease. Lentera Perawat, 6(1), 162–168. https://doi.org/10.52235/lp.v6i1.414
Istiqlala, D. R. (2024). Pemetaan kejadian kasus Demam Berdarah Dengue di Kabupaten Kediri tahun 2023. Public Health Journal, 1(2), 49-52.
Jayarajah, U., Lahiru, M., De Zoysa, I., & Seneviratne, S. L. (2021). Dengue infections and the surgical patient. American Journal of Tropical Medicine and Hygiene, 104(1), 52–59.
Kalimuddin, S., Chia, P. Y., Low, J. G., & Ooi, E. E. (2025). Dengue and severe dengue. Clinical Microbiology Reviews, 38(4), e0024424.
Kangussu, L. M., Costa, V. V., Olivon, V. C., Queiroz-Junior, C. M., Gondim, A. N. S., Melo, M. B., Reis, D., Nóbrega, N., Araújo, N., Rachid, M. A., Souza, R. P., Tirapelli, C. R., Santos, R. A. S. D., Cruz, J. D. S., Teixeira, M. M., Souza, D. D. G., & Bonaventura, D. (2022). Dengue virus infection induces inflammation and oxidative stress on the heart. Heart, 108(5), 388–396.
Kementerian Kesehatan Republik Indonesia. (2023). Profil Kesehatan Indonesia Tahun 2023. Jakarta: Kemenkes RI.
Kementerian Kesehatan Republik Indonesia. (2024). Pedoman Pencegahan Demam Berdarah Dengue. Jakarta: Kemenkes RI.
Kothari, D., Patel, N., & Bishoyi, A. K. (2025). Dengue: Epidemiology, diagnosis methods, treatment options, and prevention strategies. Archives of Virology, 170(3), 48.
Liang, X., Dang, S., Liang, S., Li, Z., Su, R., Wu, J., & Deng, H. (2025). Safety of low-dose ibuprofen in non-severe dengue patients for managing fever is consistent with acetaminophen: A retrospective observational study. Journal of Medical Virology, 97(8), e70513.
Moallemi, S., Lloyd, A. R., & Rodrigo, C. (2023). Early biomarkers for prediction of severe manifestations of dengue fever: A systematic review and a meta-analysis. Scientific Reports, 13(1), 17485.
Muhsen, I. N., Galeano, S., Niederwieser, D., Koh, M. B. C., Ljungman, P., Machado, C. M., Kharfan-Dabaja, M. A., de la Camara, R., Kodera, Y., Szer, J., Rasheed, W., Cesaro, S., Hashmi, S. K., Seber, A., Atsuta, Y., Saleh, M. F. M., Srivastava, A., Styczynski, J., Alrajhi, A., Almaghrabi, R., Abid, M. B., Chemaly, R. F., Gergis, U., Brissot, E., El Fakih, R., Riches, M., Mikulska, M., Worel, N., Weisdorf, D., Greinix, H., Cordonnier, C., Aljurf, M. (2023). Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: A Worldwide Network for Blood and Marrow Transplantation review. The Lancet Haematology, 10(4), e284–e294.
Naderian, R., Paraandavaji, E., Maddah, A. H., Keshavarzi, S., Habibian, A., Naderian, R., Hosseini, S. M., Oksenych, V., & Eslami, M. (2025). Pathophysiology and clinical implications of dengue-associated neurological disorders. Frontiers in Microbiology, 16, 1536955.
Ng, W. L., Toh, J. Y., Ng, C. J., Teo, C. H., Lee, Y. K., Loo, K. K., Abdul Hadi, H., & Noor Azhar, A. M. (2023). Self-care practices and health-seeking behaviours in patients with dengue fever: A qualitative study from patients’ and physicians’ perspectives. PLOS Neglected Tropical Diseases, 17(4), e0011302.
Nitinai, N., Nasomsong, W., Chuerboonchai, W., Tweekittikul, A., Khingmontri, V., Panuvatvanich, B., Bangchuad, T., Pongpraijaroen, M., Roongfa-Ngarm, T., & Vasikasin, V. (2024). Effect of montelukast in preventing dengue with warning signs among patients with dengue: A multicenter, randomized, double-blind, placebo-controlled trial. PLOS Neglected Tropical Diseases, 18(2), e0011927.
Okpanachi, R. O., Omatola, C. A., Abraham, J. O., Okolo, M. O., Conco-Biyela, T., Onoja, A. B., & Adamu, A. M. (2025). Dengue virus infection amongst malaria and typhoid fever suspected acute febrile patients in the Niger river basin of Nigeria. Scientific Reports, 16(1), 1699.
Paz-Bailey, G., Adams, L. E., Deen, J., Anderson, K. B., & Katzelnick, L. C. (2024). Dengue. The Lancet, 403(10427), 667–682.
Paz-Bailey, G., Adams, L., Wong, J. M., Poehling, K. A., Chen, W. H., McNally, V., Atmar, R. L., & Waterman, S. H. (2021). Dengue vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recommendations and Reports, 70(6), 1–16.
Pham, O. K., Duong, T. B., Phan, T. V., Truong, T. N., Ha, D. T. H., Nguyen, H. V., Hien, V. T. M., Dong, T. H. K., Vuong, N. L., Yen, L. M., Yacoub, S., Thwaites, C. L., & Tam, D. T. H. (2025). Severe dengue in adults: Clinical features from the 2022 dengue outbreak at a Vietnamese tertiary hospital. PLOS Neglected Tropical Diseases, 19(10), e0013589.
Robert, S., Diagbouga, P. S., Djibougou, A. D., Guy, D., Bagnall, R., & Ravel, F. (2025). Dengue diagnosis and impact on clinical management: A literature review. PLOS Neglected Tropical Diseases, 19(6), e0013196.
Rothman, A. L., & Friberg, H. (2026). Dengue fever vaccines: Progress and challenges. Annual Review of Pharmacology and Toxicology, 66(1), 129–147.
Sangkaew, S., Ming, D., Boonyasiri, A., Honeyford, K., Kalayanarooj, S., Yacoub, S., Dorigatti, I., & Holmes, A. (2021). Risk predictors of progression to severe disease during the febrile phase of dengue: A systematic review and meta-analysis. The Lancet Infectious Diseases, 21(7), 1014–1026.
Setiawati, S., Ferdi, R., & Jian, L. W. (2024). Implementation of hyperthermia management with warm compress technique in fever convulsive children: A case study. Indonesian Journal of Health Services, 1(3), 106-115. https://doi.org/10.63202/ijhs.v1i3.15
Singh, S., Verma, A. K., Chowdhary, N., Sharma, S., & Awasthi, A. (2023). Dengue havoc: Overview and eco-friendly strategies to forestall the current epidemic. Environmental Science and Pollution Research International, 30(60), 124806–124828.
Sumantri, A. W. (2025). Relationship between knowledge, education, and support of health workers on mosquito nest eradication behavior in Kedaton community health center: A cross-sectional study. Lentera Perawat, 6(4), 641–648. https://doi.org/10.52235/lp.v6i4.478
Talavera-Aguilar, L. G., Baak-Baak, C. M., Cetina-Trejo, R. C., Salazar-Vazquez, P. E., Tzuc-Dzul, J. C., Chi-Chim, W. A., Jimenez-Coello, M., Ortega-Pacheco, A., Melby, P. C., Aguilar, P. V., Walker, D. H., Cabada, M. M., & Garcia-Rejon, J. E. (2026). Surveillance for dengue virus and other pathogens in patients with acute undifferentiated febrile illnesses in Yucatan, Mexico, during the final phase of the coronavirus disease 2019 pandemic. American Journal of Tropical Medicine and Hygiene, 114(1), 161–169.
Trivedi, S., & Chakravarty, A. (2022). Neurological complications of dengue fever. Current Neurology and Neuroscience Reports, 22(8), 515–529.
Witte, P., Venturini, S., Meyer, H., Zeller, A., & Christ, M. (2024). Dengue fever—Diagnosis, risk stratification, and treatment. Deutsches Ärzteblatt International, 121(23), 773–778.
Wiwiet Susan Amelia, Yulis Marita, & Husen, A. K. B. (2025). Relationship between Knowledge and Attitude towards Dengue Fever Prevention. Lentera Perawat, 6(1), 52–58. https://doi.org/10.52235/lp.v6i1.424
Wong, J. M., Adams, L. E., Durbin, A. P., Muñoz-Jordán, J. L., Poehling, K. A., Sánchez-González, L. M., Volkman, H. R., & Paz-Bailey, G. (2022). Dengue: A growing problem with new interventions. Pediatrics, 149(6).
Yang, J., Mosabbir, A. A., Raheem, E., Hu, W., & Hossain, M. S. (2023). Demographic characteristics, clinical symptoms, biochemical markers and probability of occurrence of severe dengue: A multicenter hospital-based study in Bangladesh. PLOS Neglected Tropical Diseases, 17(3), e0011161.
Yuan, K., Chen, Y., Zhong, M., Lin, Y., & Liu, L. (2022). Risk and predictive factors for severe dengue infection: A systematic review and meta-analysis. PLOS ONE, 17(4), e0267186.
Zambrano, A., Trilleras, J., Arana, V. A., Lima, K. M. G., Neves, A. C. O., Morais, C. L. M., Romero, C., Falconar, A. K. I., Muñoz, B. S., García, R., & Carmona, C. (2025). ATR-FTIR and multivariate analysis for differential diagnosis of dengue and leptospirosis: A feasibility study. Scientific Reports, 15(1), 34092.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Toto Harto, Roni Ferdi, Desta Rahmawati
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
